US2021228768A1PendingUtilityA1
Wound dressing comprising hyaluronic acid-calcium and polylysine and manufacturing method therefor
Est. expiryJul 26, 2037(~11 yrs left)· nominal 20-yr term from priority
A61L 2400/04A61L 15/425A61L 15/32A61L 15/28A61L 15/225A61L 2300/424A61L 2300/404A61L 26/0066A61K 31/728B29C 35/16A61K 31/785A61L 2300/10A61L 15/64A61L 15/46A61L 2300/418A61L 26/0052A61L 2300/252A61L 26/0085A61L 2300/236B29L 2031/753A61L 15/44A61L 26/009B29K 2105/04
33
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a wound dressing comprising hyaluronic acid-calcium and polylysine, and a manufacturing method therefor, the method comprising: (1) a step for adjusting each of the pH values of a hyaluronic acid-calcium salt and a polylysine aqueous solution to 8.4 or higher, and then mixing the hyaluronic acid-calcium salt and the polylysine aqueous solution to obtain a mixture liquid; and (2) obtaining a wound dressing from the mixture liquid obtained in Step (1).
Claims
exact text as granted — not AI-modified1 . A wound dressing comprising hyaluronic acid-calcium and polylysine.
2 . The wound dressing according to claim 1 , comprising the hyaluronic acid-calcium and polylysine in a ratio of 4:1 to 1:1.5 by weight.
3 . The wound dressing according to claim 1 , comprising the hyaluronic acid-calcium and polylysine in a ratio of 2:1 to 4:3 by weight.
4 . The wound dressing according to claim 1 , comprising the hyaluronic acid-calcium and polylysine in a ratio of 2:1 to 1:1.5 by weight.
5 . The wound dressing according to claim 1 , wherein the hyaluronic acid has a molecular weight of 2×10 6 to 3×10 6 Da.
6 . The wound dressing according to claim 1 , wherein the wound dressing is in a form of liquid, foam or film.
7 . A method for preparing a wound dressing according to claim 1 , comprising:
(1) mixing an aqueous hyaluronic acid-calcium salt adjusted to pH 8.4 or higher with an aqueous polylysine adjusted to pH 8.4 or higher, and (2) obtaining a wound dressing from a mixed solution obtained in Step (1).
8 . The method according to claim 7 , wherein each of the pH values of the aqueous hyaluronic acid-calcium salt and the aqueous polylysine is adjusted to a range of 8.4 to 9.0 in Step (1).
9 . The method according to claim 7 , wherein a liquid-type wound dressing is obtained from the mixed solution in Step (2).
10 . The method according to claim 7 , wherein the mixed solution is freeze-dried to obtain a foam-type wound dressing in Step (2).
11 . The method according to claim 7 , wherein the mixed solution is applied onto a substrate or poured into a mold, and then dried to obtain a film-type wound dressing in Step (2).Join the waitlist — get patent alerts
Track US2021228768A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.